Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Pharmacology in Gender-Affirming Care



Speaker
Carol A. Ott (she/her), Pharm.D., BCPP
(pronouns: she/her)
Clinical Professor of Pharmacy Practice
Clinical Pharmacy Specialist
Psychiatry and Gender Health
Eskenazi Health
Purdue University College of Pharmacy

Learning Objectives
  • Identify evidence-based treatment guidelines used in gender-affirming care
  • Recognize the hormone therapies of gender-affirming care
  • Examine the occurrence of mental health symptoms and disorders in gender-diverse individuals
  • Assess medication management options for mental health disorders in gender-affirming care

Instructions
This program consists of one video and downloadable resources in PDF format.
 
To begin, scroll to the bottom of this page and click the green "Purchase Now" button. You will then be asked to log in or create an account. If you have taken a course with UT Pharmacy CE previously, be sure to use the same login as before. Once you are logged in, you can complete the registration and then take the course. After you have registered, you will be able to access this course at any time until the expiration date. 
 
Speaker information and disclosures can be found in the tab below.   

 

Fee

$20.00

CE Hours

1.00

CE Units

0.100

Support/Credits

Continuing Education Credit
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.10 CEUs (1.00 contact hour) of continuing education credit. To receive 1.00 contact hour of CE credit, the participant must watch the included video in its entirety, pass the online post-test ( >70% within 5 attempts), and complete the online evaluation. Upon successfully completing the course evaluation, the continuing pharmacy education credits will automatically be uploaded to CPE Monitor (allow 3-7 days).
 

 

 

 

Pharmacology in Gender-Affirming Care
 
About the Speaker 
Carol A. Ott (she/her), Pharm.D., BCPP
(pronouns: she/her)
Clinical Professor of Pharmacy Practice
Clinical Pharmacy Specialist
Psychiatry and Gender Health
Eskenazi Health
Purdue University College of Pharmacy
Carol Ott, Pharm.D., BCPP is a clinical professor of pharmacy practice at the Purdue University College of Pharmacy and adjunct faculty in the Department of Psychiatry at the Indiana University School of Medicine. She teaches psychiatric and neurologic pharmacotherapy at Purdue and didactics in psychopharmacology in the IU Psychiatry Residency Program. Carol is a clinical pharmacy specialist in outpatient psychiatry and gender health at Eskenazi Health in Indianapolis, working under collaborative practice agreements in the Gender Health program to provide medication management and monitoring services. At Purdue, Dr. Ott is the faculty lead for mental health and gender health in the Center for Health Equity and Innovation (CHEqI). She serves as the faculty advisor for AAPP Purdue student chapter and QueerRx in the College of Pharmacy. Dr. Ott is a member of the Indiana Medicaid Drug Utilization Review Board, Psychotropic Medication Advisory Committee, and Mental Health Quality Advisory Committee and serves as an expert panelist for the Project ECHO for Opioid Use Disorders through the IU School of Medicine and the LGBTQ+ ECHO through IU Fairbanks School of Public Health. She is a past secretary of the board of directors for the American Association of Psychiatric Pharmacists (AAPP) and a past member of the AAPP Foundation Board. Dr. Ott is an editor for the AAPP Psychiatric Pharmacotherapy Review Course for Board Certification in Psychiatric Pharmacy (BCPP). In the Lafayette, Indiana community, Dr. Ott is the president of the board of directors for NAMI West Central Indiana and serves on the executive board of the Gateway to Hope Syringe Service Program for the Tippecanoe County Health Department.  
Disclosure: Dr. Carol Ott does relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence). 


 

Activity Number

0067-0000-23-170-H01-P/T

Release Date: Oct 27, 2023
Credit Expiration Date: Oct 26, 2026

CE Hours

1.00